Author:
Mirza Sarah L.,Upton Paul D.,Hodgson Joshua,Gräf Stefan,Morrell Nicholas W.,Dunmore Benjamin J.
Reference38 articles.
1. Pulmonary arterial hypertension;Farber;N. Engl. J. Med.,2004
2. Pulmonary arterial hypertension: pathogenesis and clinical management;Thenappan;BMJ,2018
3. An emerging class of new therapeutics targeting TGF, Activin, and BMP ligands in pulmonary arterial hypertension;Upton;Dev. Dyn.,2022
4. Heterozygous germline mutations in BMPR2, encoding a TGF-beta receptor, cause familial primary pulmonary hypertension;International, P.P.H.C;Nat. Genet.,2000
5. Familial primary pulmonary hypertension (gene PPH1) is caused by mutations in the bone morphogenetic protein receptor-II gene;Deng;Am. J. Hum. Genet.,2000